China National Accord Medicines Corp Ltd
SZSE:000028
Intrinsic Value
China National Accord Medicines Corp. Ltd. engages in the research, development, and consultation services of pharmaceutical packaging materials and pharmaceutical industry products. [ Read More ]
The intrinsic value of one China National Accord Medicines Corp Ltd stock under the Base Case scenario is 86.64 CNY. Compared to the current market price of 34.44 CNY, China National Accord Medicines Corp Ltd is Undervalued by 60%.
Valuation Backtest
China National Accord Medicines Corp Ltd
Run backtest to discover the historical profit from buying and selling China National Accord Medicines Corp Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
China National Accord Medicines Corp Ltd
| Current Assets | 38.8B |
| Cash & Short-Term Investments | 5.4B |
| Receivables | 24.1B |
| Other Current Assets | 9.3B |
| Non-Current Assets | 11B |
| Long-Term Investments | 3B |
| PP&E | 3.6B |
| Intangibles | 3.4B |
| Other Non-Current Assets | 1.1B |
| Current Liabilities | 27.6B |
| Accounts Payable | 11.9B |
| Accrued Liabilities | 752.7m |
| Short-Term Debt | 11.5B |
| Other Current Liabilities | 3.4B |
| Non-Current Liabilities | 5.7B |
| Long-Term Debt | 1.4B |
| Other Non-Current Liabilities | 4.3B |
Earnings Waterfall
China National Accord Medicines Corp Ltd
|
Revenue
|
75.4B
CNY
|
|
Cost of Revenue
|
-66.4B
CNY
|
|
Gross Profit
|
9B
CNY
|
|
Operating Expenses
|
-6.6B
CNY
|
|
Operating Income
|
2.4B
CNY
|
|
Other Expenses
|
-783.2m
CNY
|
|
Net Income
|
1.6B
CNY
|
Free Cash Flow Analysis
China National Accord Medicines Corp Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
China National Accord Medicines Corp Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
China National Accord Medicines Corp Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China National Accord Medicines Corp Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
China National Accord Medicines Corp Ltd's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
China National Accord Medicines Corp Ltd
According to Wall Street analysts, the average 1-year price target for China National Accord Medicines Corp Ltd is 39.15 CNY with a low forecast of 25.25 CNY and a high forecast of 50.4 CNY.
Shareholder Return
Price
China National Accord Medicines Corp Ltd
| Average Annual Return | -6.76% |
| Standard Deviation of Annual Returns | 6.35% |
| Max Drawdown | -59% |
| Market Capitalization | 16.8B CNY |
| Shares Outstanding | 485 214 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
China National Accord Medicines Corp. Ltd. engages in the research, development, and consultation services of pharmaceutical packaging materials and pharmaceutical industry products. The company is headquartered in Shenzhen, Guangdong and currently employs 39,386 full-time employees. The firm's main products include antibiotic preparations, power injections, antibiotic Active Pharmaceutical Ingredients (APIs), respiratory system drugs and cardiovascular and cerebrovascular system drugs, among others. The firm is also involved in the provision of logistics and storage services, leasing services and training services, among others. The firm distributes its products mainly in domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one China National Accord Medicines Corp Ltd stock under the Base Case scenario is 86.64 CNY.
Compared to the current market price of 34.44 CNY, China National Accord Medicines Corp Ltd is Undervalued by 60%.
You don't have any saved screeners yet
